Literature DB >> 19125709

Malignant pleural mesothelioma treated in Clinic for Pulmonary Diseases and Tuberculosis "Podhrastovi" in ten-year period (from 1998 to 2007).

Vesna Cukić1, Aida Ustamujić, Vladimir Lovre, Hasan Zutić, Sadika Genjac, Mina Masić-Zecević.   

Abstract

Malignant pleural mesothelioma (MPM) is the most common primary malign tumour of pleura. The aim of this study was to evaluate cases of MPM diagnosed and treated in Clinic for Pulmonary Diseases and Tuberculosis "Podhrastovi" during ten-year period (1998-2007). Study is retrospective. The patients were analysed according to age, sex, histopathologic type of the tumour, cantonal distribution in Federation of Bosnia and Herzegovina and regimen of treatment. MPM presented 0,72% (0-1,56% per year) of all hospitalised malignant patients, and the greatest number of registered cases was in the year of 2007. The series included 16 male (57,14%) and 12 female (42,86%). Cases over 64 years old were the most frequent (14-50%) than 45-54 years (7- not 25%). Histopathology types of hospitalised cases of MPM: epitheloid form (8- 28,57%); sarcomatoid form (2- 7,14 %); other forms (18-64,29%). The most patients came from Canton Sarajevo (12-42,86%); ZE-DO canton (8-28,57%) and the UNA-SANA canton (5-17,86%). The therapy applied: chemotherapy (11-39,29%); radiotherapy (3-10,71%); chemotherapy + radiotherapy (4-14,29%); symptomatic therapy (10-35,71 %).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19125709      PMCID: PMC5677282          DOI: 10.17305/bjbms.2008.2898

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  14 in total

1.  Introduction to the methods used in the generation of the British Thoracic Society guidelines for the management of pleural diseases.

Authors:  R J O Davies; F V Gleeson
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

2.  Finger clubbing in malignant mesothelioma and benign asbestos pleural disease.

Authors:  C McGavin; P Hughes
Journal:  Respir Med       Date:  1998-04       Impact factor: 3.415

3.  Routes of asbestos exposure and the development of mesothelioma in an English region.

Authors:  D Howel; L Arblaster; L Swinburne; M Schweiger; E Renvoize; P Hatton
Journal:  Occup Environ Med       Date:  1997-06       Impact factor: 4.402

4.  The clinical aspects of mesothelioma.

Authors:  P C Elmes; J C Simpson
Journal:  Q J Med       Date:  1976-07

5.  Soluble mesothelin-related peptides in the diagnosis of malignant pleural mesothelioma.

Authors:  Arnaud Scherpereel; Bogdan Grigoriu; Massimo Conti; Thomas Gey; Marc Grégoire; Marie-Christine Copin; Patrick Devos; Bachar Chahine; Henri Porte; Philippe Lassalle
Journal:  Am J Respir Crit Care Med       Date:  2006-02-02       Impact factor: 21.405

6.  Malignant mesothelioma of the pleura: relation between histological type and clinical behaviour.

Authors:  M R Law; M E Hodson; B E Heard
Journal:  Thorax       Date:  1982-11       Impact factor: 9.139

7.  Prognostic factors and survival in malignant pleural mesothelioma.

Authors:  T Van Gelder; R A Damhuis; H C Hoogsteden
Journal:  Eur Respir J       Date:  1994-06       Impact factor: 16.671

8.  Mesothelioma trends in the United States: an update based on Surveillance, Epidemiology, and End Results Program data for 1973 through 2003.

Authors:  Bertram Price; Adam Ware
Journal:  Am J Epidemiol       Date:  2004-01-15       Impact factor: 4.897

9.  The French National Mesothelioma Surveillance Program.

Authors:  M Goldberg; E Imbernon; P Rolland; A Gilg Soit Ilg; M Savès; A de Quillacq; C Frenay; S Chamming's; P Arveux; C Boutin; G Launoy; J C Pairon; P Astoul; F Galateau-Sallé; P Brochard
Journal:  Occup Environ Med       Date:  2006-02-09       Impact factor: 4.402

10.  Survival of asbestos insulation workers with mesothelioma.

Authors:  J Ribak; I J Selikoff
Journal:  Br J Ind Med       Date:  1992-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.